A straightforward and fully stereoselective synthesis of a new class of peptidomimetics, that is alpha-oxo-gamma-acylaminoamides, was achieved starting from various benzaldehydes by a sequence of 1) an asymmetric organocatalytic Mannich reaction, 2) a Passerini multicomponent reaction, 3) an amine deprotection–acyl migration protocol, and 4) a final oxidation. The whole sequence can be performed without purification of the intermediates and represents the first example of a homo-Passerini– amine deprotection–acyl migration (PADAM) strategy. Highly stereoselective reduction of the alpha-oxo-gamma-acylaminoamides afforded alpha-hydroxy-gamma-acylaminoamides as well. In some cases both diastereomers were obtained by simply changing the reducing agent. Finally, starting from protected salicylaldehyde, the same sequence, followed by a Mitsunobu cyclization, afforded highly substituted chromanes.
The homo-PADAM Protocol: Stereoselective and Operationally Simple Synthesis of alpha-Oxo or alpha-Hydroxy-gamma-acylaminoamides and Chromanes
MORANA, FABIO;BASSO, ANDREA;ROCCA, VALERIA MARISA;RIVA, RENATA;BANFI, LUCA
2013-01-01
Abstract
A straightforward and fully stereoselective synthesis of a new class of peptidomimetics, that is alpha-oxo-gamma-acylaminoamides, was achieved starting from various benzaldehydes by a sequence of 1) an asymmetric organocatalytic Mannich reaction, 2) a Passerini multicomponent reaction, 3) an amine deprotection–acyl migration protocol, and 4) a final oxidation. The whole sequence can be performed without purification of the intermediates and represents the first example of a homo-Passerini– amine deprotection–acyl migration (PADAM) strategy. Highly stereoselective reduction of the alpha-oxo-gamma-acylaminoamides afforded alpha-hydroxy-gamma-acylaminoamides as well. In some cases both diastereomers were obtained by simply changing the reducing agent. Finally, starting from protected salicylaldehyde, the same sequence, followed by a Mitsunobu cyclization, afforded highly substituted chromanes.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.